Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men

Hypertension

Volumn 34, Issue 5, 1999, Pages 1047-1052

  Paolisso, Giuseppe ^a,c   Tagliamonte, Maria Rosaria ^a   Galderisi, Maurizio ^b   Zito, Guido Antonio ^a   Petrocelli, Antonio ^b   Carella, Carlo ^b   De Divitiis, Oreste ^b   Varricchio, Michele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Servizio di Astanteria Medica   (Italy)

Author keywords

Hypertension, arterial; Hypertension, essential; Insulin; Leptin

Indexed keywords

INSULIN; LEPTIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CASE REPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL;

EID: 0032707747     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1047     Document Type: Article

References (35)

1. Zangh Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
2. Halaas JL, Gajiwalla KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543-546.
3. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81: 3424-3427.
4. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens. 1997;10:1171-1174.
5. Casto RM, Van Ness JM, Overton JM. Effects of central leptin administration on blood pressure in normotensive rats. Neurosci Lett. 1998;246: 29-32.
6. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409-414.
7. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-381.
8. Shimuzu M, Sughiara N, Kita Y, Shimuzu M, Horita Y, Nakaijama K, Taki J, Takeda R. Long term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy. Br Heart J. 1992; 67:155-160.
9. Deurenberg P, Van der Koij E, Evers P, Hulshof T. Assessment of body composition by bioelectrical impedance in a population aged >60 years. Am J Clin Nutr. 1990;51:3-6.
10. Sahn DJ, De Maria A, Kisslo J, Weiman A, for the Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
11. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in men. Circulation. 1997;55:613-618.
12. Levy D, Savage DD, Garrison RJ, Anderson KM, Kanneòl WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956-960.
13. Galderisi M, Lauer MS, Levy D. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol. 1992;70:971-976.
14. Diabetes Mellitus: A Report of a WHO Study Group. World Health Organization; 1985;727:9-17.
15. De Fronzo RA, Tobin JD, Anderson R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
16. Bonadonna RC, Saccomani MP, Seely L, Zych KS, Ferrannini E, Cobelli C, DeFronzo RA. Glucose transport in human skeletal muscle: the in vivo response to insulin. Diabetes. 1983;32:35-41.
17. De Fronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983;32:35-41.
18. Paolisso G, Gambardella A, Balbi V, Galzerano D, Verza M, Varricchio M, D'Onofrio F. Effects of magnesium and nifedipine on insulin action, substrate oxidation and blood pressure in aged hypertensive patients. Am J Hypertens. 1993;6:920-926.
19. Ferrannini E. The theoretical basis of indirect calorimetry: a review. Metabolism. 1988;37:287-301.
20. Paolisso G, Galderisi M, Tagliamonte MR, de Divitiis M, Galzerano D, Petrocelli A, Gualdiero P, de Divitiis O, Varricchio M. Myocardial wall thickness and left ventricular geometry in hypertensives: relationship with insulin. Am J Hypertens. 1997;10:1250-1256.
21. Snikter S, Pratley RE, Nicolson M, Tataranni PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res. 1997;5:338-340.
22. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-278.
23. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46:2040-2043.
24. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30:619-623.
25. Safar ME, Lehner Vincent MI, Plainfosse MT, Simon AC. Echocardiographic dimension in borderline and sustained hypertension. Am J Cardiol. 1979;44:930-935.
26. Gainsford T, Wilson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ. Leptin can induce proliferation, differentiation, and functional activation of haemopoietic cells. Proc Natl Acad Sci U S A. 1996;93:14564-14568.
27. Umemoto Y, Tsuji K, Yang FC, Ebihara Y, Kaneko A, Furukawa S, Nakahata T. Leptin stimulates the proliferation of murine myelocytic and primitive haematopoietic progenitor cells. Blood. 1997;90:3438-3443.
28. Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol. 1997;11:393-399.
29. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998;47:544-549.
30. Williams KV, Mullen M, Lang W, Considine RV, Wing RR. Weight loss and leptin changes in individuals with type II diabetes. Obes Res. 1999; 7:155-163.
31. Karason K, Wallentin I, Larsson B, Sjostrom L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. Br Med J. 1997;315:912-916.
32. Takahashi Y, Okimura Y, Mizuno I, Iida K, Takahashi T, Kaji H, Abe H, Chihara K. Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem. 1997;272:12897-12900.
33. Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationship with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab. 1996;81: 4433-4438.
34. Pratley RE, Nicolson M, Bogardus C, Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. J Clin Endocrinol Metab. 1996;81: 4418-4421.
35. Tuominen JA, Ebeling P, Stenman UH, Heiman ML, Stephens TW, Koivisto VA. Leptin synthesis is resistant to acute effects of insulin in insulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1997;82:381-382.